John E. Kao Sells 90,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHCGet Free Report) CEO John E. Kao sold 90,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $15.36, for a total transaction of $1,382,400.00. Following the sale, the chief executive officer now directly owns 2,093,100 shares of the company’s stock, valued at $32,150,016. The trade was a 4.12 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Alignment Healthcare Price Performance

Shares of ALHC opened at $15.79 on Friday. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $16.25. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The stock has a fifty day moving average price of $14.38 and a 200 day moving average price of $12.41. The company has a market cap of $3.03 billion, a P/E ratio of -20.51 and a beta of 1.49.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Barclays increased their price objective on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research note on Friday, February 28th. Piper Sandler lifted their price target on Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. Stifel Nicolaus upped their price objective on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Friday, February 28th. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Finally, Bank of America boosted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $14.83.

Get Our Latest Stock Report on Alignment Healthcare

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors have recently modified their holdings of the company. Principal Financial Group Inc. boosted its stake in Alignment Healthcare by 1,335.1% during the 3rd quarter. Principal Financial Group Inc. now owns 194,043 shares of the company’s stock valued at $2,294,000 after purchasing an additional 180,522 shares during the period. Royce & Associates LP bought a new stake in shares of Alignment Healthcare during the third quarter valued at approximately $3,782,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Alignment Healthcare during the third quarter worth approximately $131,000. Intech Investment Management LLC bought a new position in Alignment Healthcare in the 3rd quarter worth approximately $315,000. Finally, Charles Schwab Investment Management Inc. increased its position in Alignment Healthcare by 1.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company’s stock valued at $9,925,000 after acquiring an additional 13,865 shares during the period. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Read More

Insider Buying and Selling by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.